Enhancement of Mesenchymal Stem Cell-Driven Bone Regeneration by Resveratrol-Mediated SOX2 Regulation
Overview
Authors
Affiliations
Mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine. However, MSCs age rapidly during long-term culture and lose their therapeutic potential before they reach effective cell doses (ECD) for cell therapy. Thus, a prerequisite for effective MSC therapy is the development of cell culture methods to preserve the therapeutic potential during long-term cultivation. Resveratrol (RSV) has been highlighted as a therapeutic candidate for bone disease. Although RSV treatment has beneficial effects on bone-forming cells, studies are lacking. The current study showed that long-term (6 weeks from primary culture date)-cultured MSCs with RSV induction retained their proliferative and differentiation potential despite reaching ECD. The mechanism of RSV action depends entirely on the SIRT1-SOX2 axis in MSC culture. In a rat calvarial defect model, RSV induction significantly improved bone regeneration after MSC transplantation. This study demonstrated an example of efficient MSC therapy for treating bone defects by providing a new strategy using the plant polyphenol RSV.
Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.
Wu K, Chang Y, Ding D, Lin S Int J Mol Sci. 2024; 25(23.
PMID: 39684619 PMC: 11641625. DOI: 10.3390/ijms252312911.
Guo Q, Zhai Q, Ji P Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458939 PMC: 11510265. DOI: 10.3390/ph17101297.
Hanga-Farcas A, Miere Groza F, Filip G, Clichici S, Fritea L, Vicas L Plants (Basel). 2023; 12(10).
PMID: 37653972 PMC: 10222459. DOI: 10.3390/plants12102055.
Ahmadi A, Mazloomnejad R, Kasravi M, Gholamine B, Bahrami S, Sarzaeem M Stem Cell Res Ther. 2022; 13(1):518.
PMID: 36371202 PMC: 9652959. DOI: 10.1186/s13287-022-03204-4.
Irfan F, Jameel F, Khan I, Aslam R, Faizi S, Salim A Regen Ther. 2022; 21:225-238.
PMID: 36092499 PMC: 9420879. DOI: 10.1016/j.reth.2022.07.011.